{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T12:09:34Z","timestamp":1745582974785,"version":"3.37.3"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The study evaluates associations between serum vitamin D metabolites at diagnosis and one-year remission, in early diagnosed rheumatoid arthritis(RA). The CIMESTRA-cohort comprised 160 newly diagnosed RA patients, treated aiming at remission. Vitamin D supplementation was recommended according to national guidelines. D<jats:sub>total<\/jats:sub>(25OHD<jats:sub>2<\/jats:sub>\u2009+\u200925OHD<jats:sub>3<\/jats:sub>) was dichotomized at 50 nmol\/L, 1,25(OH)<jats:sub>2<\/jats:sub>D was categorized in tertiles. Primary outcome was remission(DAS28-CRP\u2009\u2264\u20092.6) after one year. Associations were evaluated using logistic regression, further adjusted for pre-specified potential confounders: Age, sex, symptom-duration before diagnosis, DAS28-CRP and season of diagnosis. Results are presented as Odds Ratios(OR) with 95% Confidence Intervals(95%CIs). In univariate analyses, neither D<jats:sub>total<\/jats:sub> nor 1,25(OH)<jats:sub>2<\/jats:sub>D were associated with remission. In adjusted analyses, low D<jats:sub>total<\/jats:sub> was associated with higher odds for remission; OR 2.6, 95%CI (1.1; 5.9) p\u2009=\u20090.03, with season impacting results the most. One-year remission was lower in patients with diagnosis established at winter. In conclusion, low D<jats:sub>total<\/jats:sub> at diagnosis was associated with increased probability of achieving one-year remission in early RA when adjusting for covariates. Diagnosis in winter was associated with lower odds for one-year remission. Results suggest that season act as a contextual factor potentially confounding associations between vitamin D and RA disease-course. The finding of low D<jats:sub>total<\/jats:sub> being associated with higher one-year remission remains speculative.<\/jats:p>","DOI":"10.1038\/s41598-020-64284-x","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T10:02:59Z","timestamp":1588240979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Impact of season on the association between vitamin D levels at diagnosis and one-year remission in early Rheumatoid Arthritis"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3100-0850","authenticated-orcid":false,"given":"M.","family":"Herly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0779-8054","authenticated-orcid":false,"given":"K.","family":"Stengaard-Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9046-2967","authenticated-orcid":false,"given":"P.","family":"Vestergaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6600-0631","authenticated-orcid":false,"given":"R.","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0858-4269","authenticated-orcid":false,"given":"S.","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3690-467X","authenticated-orcid":false,"given":"M.","family":"\u00d8stergaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2684-9964","authenticated-orcid":false,"given":"P.","family":"Junker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4229-6818","authenticated-orcid":false,"given":"M. L.","family":"Hetland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5475-7610","authenticated-orcid":false,"given":"K.","family":"H\u00f8rslev-Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0426-4962","authenticated-orcid":false,"given":"T.","family":"Ellingsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,30]]},"reference":[{"key":"64284_CR1","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrrheum.2015.140","volume":"12","author":"LE Jeffery","year":"2016","unstructured":"Jeffery, L. E., Raza, K. & Hewison, M. Vitamin D in rheumatoid arthritis-towards clinical application. Nat. Rev. Rheumatol. 12, 201\u2013210, https:\/\/doi.org\/10.1038\/nrrheum.2015.140 (2016).","journal-title":"Nat. Rev. Rheumatol."},{"doi-asserted-by":"publisher","unstructured":"Sassi, F., Tamone, C. & D\u2019Amelio, P. Vitamin D: Nutrient, Hormone, and Immunomodulator. Nutrients 10, https:\/\/doi.org\/10.3390\/nu10111656 (2018).","key":"64284_CR2","DOI":"10.3390\/nu10111656"},{"key":"64284_CR3","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1056\/NEJMra070553","volume":"357","author":"MF Holick","year":"2007","unstructured":"Holick, M. F. Vitamin D deficiency. N. Engl. J. Med. 357, 266\u2013281 (2007).","journal-title":"N. Engl. J. Med."},{"issue":"Suppl 1","key":"64284_CR4","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.1079\/BJN2001345","volume":"86","author":"C Brot","year":"2001","unstructured":"Brot, C. et al. Vitamin D status and its adequacy in healthy Danish perimenopausal women: relationships to dietary intake, sun exposure and serum parathyroid hormone. Br. J. Nutr. 86(Suppl 1), S97\u2013103 (2001).","journal-title":"Br. J. Nutr."},{"key":"64284_CR5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jsbmb.2005.06.002","volume":"97","author":"EE van","year":"2005","unstructured":"van, E. E. & Mathieu, C. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J. Steroid Biochem. Mol. Biol. 97, 93\u2013101 (2005).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"64284_CR6","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/ncprheum0855","volume":"4","author":"L Adorini","year":"2008","unstructured":"Adorini, L. & Penna, G. Control of autoimmune diseases by the vitamin D endocrine system. Nat.Clin.Pract.Rheumatol. 4, 404\u2013412 (2008).","journal-title":"Nat.Clin.Pract.Rheumatol."},{"key":"64284_CR7","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nri3045","volume":"11","author":"PH Hart","year":"2011","unstructured":"Hart, P. H., Gorman, S. & Finlay-Jones, J. J. Modulation of the immune system by UV radiation: more than just the effects of vitamin D? Nat. Rev. Immunol. 11, 584\u2013596 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"64284_CR8","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1365-2265.2011.04261.x","volume":"76","author":"M Hewison","year":"2012","unstructured":"Hewison, M. An update on vitamin D and human immunity. Clin.Endocrinol.(Oxf) 76, 315\u2013325 (2012).","journal-title":"Clin.Endocrinol.(Oxf)"},{"key":"64284_CR9","doi-asserted-by":"publisher","first-page":"Itc1","DOI":"10.7326\/aitc201901010","volume":"170","author":"JA Sparks","year":"2019","unstructured":"Sparks, J. A. Rheumatoid Arthritis. Ann. Intern. Med. 170, Itc1\u2013itc16, https:\/\/doi.org\/10.7326\/aitc201901010 (2019).","journal-title":"Ann. Intern. Med."},{"key":"64284_CR10","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1007\/s11033-019-04682-1","volume":"46","author":"S Khajoei","year":"2019","unstructured":"Khajoei, S. et al. Serum levels of adiponectin and vitamin D correlate with activity of Rheumatoid Arthritis. Mol. Biol. Rep. 46, 2505\u20132512, https:\/\/doi.org\/10.1007\/s11033-019-04682-1 (2019).","journal-title":"Mol. Biol. Rep."},{"key":"64284_CR11","first-page":"827","volume":"34","author":"YH Lee","year":"2016","unstructured":"Lee, Y. H. & Bae, S. C. Vitamin D level in rheumatoid arthritis and its correlation with the disease activity: a meta-analysis. Clin. Exp. Rheumatol. 34, 827\u2013833 (2016).","journal-title":"Clin. Exp. Rheumatol."},{"key":"64284_CR12","doi-asserted-by":"publisher","first-page":"e12704","DOI":"10.1111\/sji.12704","volume":"88","author":"M Herly","year":"2018","unstructured":"Herly, M. et al. The D-vitamin metabolite 1,25(OH)2 D in serum is associated with disease activity and Anti-Citrullinated Protein Antibodies in active and treatment naive, early Rheumatoid Arthritis Patients. Scand. J. Immunol. 88, e12704, https:\/\/doi.org\/10.1111\/sji.12704 (2018).","journal-title":"Scand. J. Immunol."},{"key":"64284_CR13","doi-asserted-by":"publisher","first-page":"i1777","DOI":"10.1136\/bmj.i1777","volume":"353","author":"GS Hazlewood","year":"2016","unstructured":"Hazlewood, G. S. et al. Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: abridged Cochrane systematic review and network meta-analysis. BMJ 353, i1777, https:\/\/doi.org\/10.1136\/bmj.i1777 (2016).","journal-title":"BMJ"},{"key":"64284_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12891-015-0505-6","volume":"16","author":"FM Di","year":"2015","unstructured":"Di, F. M. et al. Hypovitaminosis D in recent onset rheumatoid arthritis is predictive of reduced response to treatment and increased disease activity: a 12 month follow-up study. BMC. Musculoskelet. Disord. 16, 53 (2015).","journal-title":"BMC. Musculoskelet. Disord."},{"key":"64284_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/rhu.0000000000000477","volume":"23","author":"MA Quintana-Duque","year":"2017","unstructured":"Quintana-Duque, M. A. et al. The Role of 25-Hydroxyvitamin D as a Predictor of Clinical and Radiological Outcomes in Early Onset Rheumatoid Arthritis. J. Clin. Rheumatol. 23, 33\u201339, https:\/\/doi.org\/10.1097\/rhu.0000000000000477 (2017).","journal-title":"J. Clin. Rheumatol."},{"key":"64284_CR16","doi-asserted-by":"publisher","first-page":"5155","DOI":"10.4049\/jimmunol.1200786","volume":"189","author":"LE Jeffery","year":"2012","unstructured":"Jeffery, L. E. et al. Availability of 25-hydroxyvitamin D(3) to APCs controls the balance between regulatory and inflammatory T cell responses. J.Immunol. 189, 5155\u20135164 (2012).","journal-title":"J.Immunol."},{"key":"64284_CR17","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/jbmr.5650060711","volume":"6","author":"EB Mawer","year":"1991","unstructured":"Mawer, E. B. et al. Evidence for nonrenal synthesis of 1,25-dihydroxyvitamin D in patients with inflammatory arthritis. J. Bone Miner. Res. 6, 733\u2013739 (1991).","journal-title":"J. Bone Miner. Res."},{"key":"64284_CR18","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.jbspin.2010.09.018","volume":"77","author":"X Guillot","year":"2010","unstructured":"Guillot, X., Semerano, L., Saidenberg-Kermanac\u2019h, N., Falgarone, G. & Boissier, M. C. Vitamin D and inflammation. Joint Bone Spine 77, 552\u2013557, https:\/\/doi.org\/10.1016\/j.jbspin.2010.09.018 (2010).","journal-title":"Joint Bone Spine"},{"key":"64284_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jaut.2017.06.001","volume":"82","author":"A Watad","year":"2017","unstructured":"Watad, A. et al. Seasonality and autoimmune diseases: The contribution of the four seasons to the mosaic of autoimmunity. J. Autoimmun. 82, 13\u201330, https:\/\/doi.org\/10.1016\/j.jaut.2017.06.001 (2017).","journal-title":"J. Autoimmun."},{"key":"64284_CR20","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1093\/rheumatology\/kel414","volume":"46","author":"N Iikuni","year":"2007","unstructured":"Iikuni, N. et al. What\u2019s in season for rheumatoid arthritis patients? Seasonal fluctuations in disease activity. Rheumatology. (Oxford) 46, 846\u2013848 (2007).","journal-title":"Rheumatology. (Oxford)"},{"key":"64284_CR21","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1136\/ard.2010.144402","volume":"70","author":"G Mouterde","year":"2011","unstructured":"Mouterde, G. et al. Predictors of radiographic progression in the ESPOIR cohort: the season of first symptoms may influence the short-term outcome in early arthritis. Ann. Rheum. Dis. 70, 1251\u20131256 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"64284_CR22","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nrrheum.2011.115","volume":"7","author":"M Cutolo","year":"2011","unstructured":"Cutolo, M. Rheumatoid arthritis: circadian and circannual rhythms in RA. Nat. Rev. Rheumatol. 7, 500\u2013502, https:\/\/doi.org\/10.1038\/nrrheum.2011.115 (2011).","journal-title":"Nat. Rev. Rheumatol."},{"key":"64284_CR23","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1615\/CritRevBiomedEng.2016018812","volume":"44","author":"RT Rao","year":"2016","unstructured":"Rao, R. T., Pierre, K. K., Schlesinger, N. & Androulakis, I. P. The Potential of Circadian Realignment in Rheumatoid Arthritis. Crit. Rev. Biomed. Eng. 44, 177\u2013191, https:\/\/doi.org\/10.1615\/CritRevBiomedEng.2016018812 (2016).","journal-title":"Crit. Rev. Biomed. Eng."},{"key":"64284_CR24","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1365-2249.2010.04315.x","volume":"164","author":"AL Khoo","year":"2011","unstructured":"Khoo, A. L. et al. Regulation of cytokine responses by seasonality of vitamin D status in healthy individuals. Clin. Exp. Immunol. 164, 72\u201379, https:\/\/doi.org\/10.1111\/j.1365-2249.2010.04315.x (2011).","journal-title":"Clin. Exp. Immunol."},{"key":"64284_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8000","volume":"6","author":"XC Dopico","year":"2015","unstructured":"Dopico, X. C. et al. Widespread seasonal gene expression reveals annual differences in human immunity and physiology. Nature communications 6, 7000, https:\/\/doi.org\/10.1038\/ncomms8000 (2015).","journal-title":"Nature communications"},{"key":"64284_CR26","doi-asserted-by":"publisher","first-page":"e0126995","DOI":"10.1371\/journal.pone.0126995","volume":"10","author":"A Goldinger","year":"2015","unstructured":"Goldinger, A. et al. Seasonal effects on gene expression. PLoS One 10, e0126995, https:\/\/doi.org\/10.1371\/journal.pone.0126995 (2015).","journal-title":"PLoS One"},{"key":"64284_CR27","doi-asserted-by":"publisher","first-page":"R83","DOI":"10.1186\/ar3353","volume":"13","author":"YC Lee","year":"2011","unstructured":"Lee, Y. C. et al. Pain persists in DAS28 rheumatoid arthritis remission but not in ACR\/EULAR remission: a longitudinal observational study. Arthritis Res. Ther. 13, R83 (2011).","journal-title":"Arthritis Res. Ther."},{"key":"64284_CR28","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/j.1756-185X.2011.01684.x","volume":"14","author":"K Gopinath","year":"2011","unstructured":"Gopinath, K. & Danda, D. Supplementation of 1,25 dihydroxy vitamin D3 in patients with treatment naive early rheumatoid arthritis: a randomised controlled trial. Int. J. Rheum. Dis. 14, 332\u2013339 (2011).","journal-title":"Int. J. Rheum. Dis."},{"key":"64284_CR29","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3109\/14397595.2014.952487","volume":"25","author":"Y Matsumoto","year":"2015","unstructured":"Matsumoto, Y. et al. Relationships between serum 25-hydroxycalciferol, vitamin D intake and disease activity in patients with rheumatoid arthritis\u2013TOMORROW study. Mod. Rheumatol. 25, 246\u2013250 (2015).","journal-title":"Mod. Rheumatol."},{"key":"64284_CR30","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/1756-185x.12770","volume":"20","author":"S Chandrashekara","year":"2017","unstructured":"Chandrashekara, S. & Patted, A. Role of vitamin D supplementation in improving disease activity in rheumatoid arthritis: An exploratory study. Int. J. Rheum. Dis. 20, 825\u2013831, https:\/\/doi.org\/10.1111\/1756-185x.12770 (2017).","journal-title":"Int. J. Rheum. Dis."},{"key":"64284_CR31","doi-asserted-by":"publisher","first-page":"R216","DOI":"10.1186\/ar3195","volume":"12","author":"M Rossini","year":"2010","unstructured":"Rossini, M. et al. Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disability. Arthritis Res. Ther. 12, R216 (2010).","journal-title":"Arthritis Res. Ther."},{"key":"64284_CR32","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.3892\/etm.2015.2747","volume":"10","author":"J Yang","year":"2015","unstructured":"Yang, J., Liu, L., Zhang, Q., Li, M. & Wang, J. Effect of vitamin D on the recurrence rate of rheumatoid arthritis. Exp. Ther. Med. 10, 1812\u20131816, https:\/\/doi.org\/10.3892\/etm.2015.2747 (2015).","journal-title":"Exp. Ther. Med."},{"key":"64284_CR33","doi-asserted-by":"publisher","first-page":"e7024","DOI":"10.1097\/md.0000000000007024","volume":"96","author":"AS Franco","year":"2017","unstructured":"Franco, A. S., Freitas, T. Q., Bernardo, W. M. & Pereira, R. M. R. Vitamin D supplementation and disease activity in patients with immune-mediated rheumatic diseases: A systematic review and meta-analysis. Medicine (Baltimore) 96, e7024, https:\/\/doi.org\/10.1097\/md.0000000000007024 (2017).","journal-title":"Medicine (Baltimore)"},{"key":"64284_CR34","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1002\/art.21796","volume":"54","author":"ML Hetland","year":"2006","unstructured":"Hetland, M. L. et al. Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled study. Arthritis Rheum. 54, 1401\u20131409 (2006).","journal-title":"Arthritis Rheum."},{"key":"64284_CR35","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1017\/s1368980010002454","volume":"14","author":"FL Crowe","year":"2011","unstructured":"Crowe, F. L. et al. Plasma concentrations of 25-hydroxyvitamin D in meat eaters, fish eaters, vegetarians and vegans: results from the EPIC-Oxford study. Public Health Nutr. 14, 340\u2013346, https:\/\/doi.org\/10.1017\/s1368980010002454 (2011).","journal-title":"Public Health Nutr."},{"key":"64284_CR36","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1017\/s0007114500001926","volume":"84","author":"WB Grant","year":"2000","unstructured":"Grant, W. B. The role of meat in the expression of rheumatoid arthritis. Br. J. Nutr. 84, 589\u2013595, https:\/\/doi.org\/10.1017\/s0007114500001926 (2000).","journal-title":"Br. J. Nutr."},{"key":"64284_CR37","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.foodchem.2012.10.032","volume":"140","author":"J Liu","year":"2013","unstructured":"Liu, J., Greenfield, H., Strobel, N. & Fraser, D. R. The influence of latitude on the concentration of vitamin D3 and 25-hydroxy-vitamin D3 in Australian red meat. Food Chem. 140, 432\u2013435, https:\/\/doi.org\/10.1016\/j.foodchem.2012.10.032 (2013).","journal-title":"Food Chem."},{"unstructured":"Medicine), I. I. o. Dietary Reference Intakes for Calcium and Vitamin D. (The National Academies Press, 2011).","key":"64284_CR38"},{"key":"64284_CR39","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jbmr.328","volume":"26","author":"RP Heaney","year":"2011","unstructured":"Heaney, R. P. & Holick, M. F. Why the IOM recommendations for vitamin D are deficient. J. Bone Miner. Res. 26, 455\u2013457, https:\/\/doi.org\/10.1002\/jbmr.328 (2011).","journal-title":"J. Bone Miner. Res."},{"key":"64284_CR40","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.cca.2009.10.010","volume":"411","author":"CS Hojskov","year":"2010","unstructured":"Hojskov, C. S., Heickendorff, L. & Moller, H. J. High-throughput liquid-liquid extraction and LCMSMS assay for determination of circulating 25(OH) vitamin D3 and D2 in the routine clinical laboratory. Clin. Chim. Acta 411, 114\u2013116 (2010).","journal-title":"Clin. Chim. Acta"},{"key":"64284_CR41","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1210\/jc.2013-3978","volume":"99","author":"L Rolighed","year":"2014","unstructured":"Rolighed, L. et al. Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trial. J. Clin. Endocrinol. Metab 99, 1072\u20131080 (2014).","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"64284_CR42","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1373\/clinchem.2006.077560","volume":"53","author":"I Seiden-Long","year":"2007","unstructured":"Seiden-Long, I. & Vieth, R. Evaluation of a 1,25-dihydroxyvitamin D enzyme immunoassay. Clin. Chem. 53, 1104\u20131108 (2007).","journal-title":"Clin. Chem."},{"key":"64284_CR43","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/acr.20188","volume":"62","author":"W Katchamart","year":"2010","unstructured":"Katchamart, W. et al. Predictors for remission in rheumatoid arthritis patients: A systematic review. Arthritis Care Res. (Hoboken.) 62, 1128\u20131143 (2010).","journal-title":"Arthritis Care Res. (Hoboken.)"},{"unstructured":"Stata Statistical Software: Release 14. College Station, TX: StataCorp LP (2014).","key":"64284_CR44"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-64284-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-64284-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-64284-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T09:44:04Z","timestamp":1670319844000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-64284-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,30]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["64284"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-64284-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2020,4,30]]},"assertion":[{"value":"24 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Herly reports grants from Pfizer Denmark, during the conduct of the study; personal fees from Danish Rheumatism Association, outside the submitted work. Dr. Christensen reports non-financial support from Board membership, grants from Consultancy (AbbVie, Amgen, Axellus A\/S, Biogen, Bristol-Myers Squibb, Cambridge Weight Plan, Celgene, Eli Lilly, Hospira, MSD, Norpharma, Novartis, Orkla Health, Pfizer, Roche, Sobi, Takeda), personal fees from Employment (Research Unit for Musculoskeletal Function and Physiotherapy, Institute of Sports Science and Clinical Biomechanics, University of Southern Denmark), non-financial support from Expert testimony, grants from Grants\/grants pending (Axellus A\/S, AbbVie, Cambridge Weight Plan, Janssen, MSD, Mundipharma, Novartis, and Roche), grants from Payment for lectures including service on speakers bureaus (Abbott, Amgen, Axellus, Bayer HealthCare Pharmaceuticals, Biogen Idec, Bristol-Myers Squibb, Cambridge Weight Plan, Ipsen, Janssen, Laboratoires Expanscience, MSD, Mundipharma, Norpharma, Novartis, Pfizer, Roche, Rottapharm-Madaus, Sobi, and Wyeth), grants from Payment for manuscript preparation (Axellus, Bristol-Myers Squibb, and Cambridge Weight Plan, Aleris-Hamlet (via Norpharma)), non-financial support from Patents (planned, pending or issued), non-financial support from Royalties, grants from Payment for development of educational presentations (Bristol-Myers Squibb, MSD, Pfizer), non-financial support from Stock\/stock options, grants from Travel\/accommodations\/meeting expenses unrelated to activities listed (Abbott, AbbVie, Axellus, Biogen, Bristol-Myers Squibb, Cambridge Weight Plan, Celgene, Laboratoires Expanscience, Norpharma, Novartis, Pfizer, Roche, Rottapharm-Madaus, and Wyeth), non-financial support from Other (err on the side of full disclosure), outside the submitted work; and I am involved in many health-care initiatives and research that could benefit from wide uptake of this publication (including Cochrane, OMERACT, IDEOM, RADS, and the GRADE Working Group). Musculoskeletal Statistics Unit, The Parker Institute is grateful for the financial support received from public and private foundations, companies and private individuals over the years. The Parker Institute is supported by a core grant from the Oak Foundation (OCAY-18\u2013774-OFIL); The Oak Foundation is a group of philanthropic organizations that, since its establishment in 1983, has given grants to not-for-profit organizations around the world. Dr. \u00d8stergaard reports grants, personal fees and non-financial support from AbbVie, grants, personal fees and non-financial support from BMS, personal fees from Boehringer-Ingelheim, personal fees from Eli Lilly, personal fees and non-financial support from Janssen, grants, personal fees and non-financial support from Merck, personal fees and non-financial support from Pfizer, personal fees and non-financial support from Roche, grants, personal fees and non-financial support from UCB, grants and personal fees from Celgene, personal fees from Sanofi, personal fees from Regeneron, grants, personal fees and non-financial support from Novartis, personal fees from Orion, personal fees from Hospira, outside the submitted work. Dr. Hetland reports grants from AbbVie, grants from Biogen, grants from BMS, personal fees from CellTrion, grants from MSD, grants from Novartis, personal fees from Orion, grants from Pfizer, personal fees from Samsung, grants from UCB, outside the submitted work. Dr. H\u00f8rslev-Petersen reports grants from travel expences (eular 2018, pfizer), outside the submitted work;. Dr. Stengaard-Pedersen, Dr. Vestergaard, Dr. M\u00f6ller, Dr. Junker and Dr. Ellingsen have nothing to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7371"}}